We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$966M
AUM Growth
+$51.6M
Cap. Flow
+$37M
Cap. Flow %
3.83%
Top 10 Hldgs %
72.41%
Holding
47
New
16
Increased
6
Reduced
12
Closed
2

Top Buys

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$57.2M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$26.2M
3
AKCA
Akcea Therapeutics Inc
AKCA
+$22.8M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$20.7M
5
RUBY
Rubius Therapeutics, Inc
RUBY
+$13.5M

Top Sells

1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$55.8M
2
ASND icon
Ascendis Pharma A/S
ASND
+$25.9M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$20.9M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$17.7M
5
WVE icon
Wave Life Sciences
WVE
+$16.6M

Sector Composition

1 Healthcare 88.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
26
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.82M 0.6%
343,231
-1,166,440
-77% -$17.7M
ACHN
27
DELISTED
Achillion Pharmaceuticals
ACHN
$5.76M 0.6%
1,564,080
-2,323,327
-60% -$6.92M
MRSN
28
DELISTED
Mersana Therapeutics
MRSN
$4.96M 0.51%
+19,825
New +$6.64M
KDMN
29
DELISTED
Kadmon Holdings, Inc.
KDMN
$4.95M 0.51%
1,480,870
-1,019,130
-41% -$3.61M
IONS icon
30
Ionis Pharmaceuticals
IONS
$9.04B
$3.73M 0.39%
+72,326
New +$3.4M
TRAW icon
31
Traws Pharma
TRAW
$9.97M
$3.67M 0.38%
1,333
– –
TECX
32
Tectonic Therapeutic
TECX
$613M
$3.56M 0.37%
+5,721
New +$2.54M
CRVS icon
33
Corvus Pharmaceuticals
CRVS
$1.25B
$3.02M 0.31%
351,401
-98,999
-22% -$990K
WVE icon
34
Wave Life Sciences
WVE
$1.14B
$2.24M 0.23%
44,841
-368,030
-89% -$16.6M
CNST
35
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$1.88M 0.2%
+280,000
New +$2.67M
FTSV
36
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1.48M 0.15%
+99,000
New +$1.48M
CHMA
37
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.37M 0.14%
+379,753
New +$794K
INFI
38
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.25M 0.13%
462,068
+50,068
+12% +$104K
APTX
39
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.19M 0.12%
41,037
– –
ARVN icon
40
Arvinas
ARVN
$534M
$844K 0.09%
+50,000
New +$823K
PHXM
41
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$590K 0.06%
6,957
-8,439
-55% -$879K
DBVT
42
DBV Technologies
DBVT
$930M
– –
-29,810
Closed -$5.75M
GILD icon
43
Gilead Sciences
GILD
$164B
– –
0
– –
MDGL icon
44
Madrigal Pharmaceuticals
MDGL
$12.7B
– –
-199,500
Closed -$55.8M
NKTR icon
45
Nektar Therapeutics
NKTR
$2.31B
– –
0
– –
JNCE
46
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
0
– –
CELG
47
DELISTED
Celgene Corp
CELG
– –
0
– –
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return